KR100468977B1 - Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same - Google Patents
Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the SameInfo
- Publication number
- KR100468977B1 KR100468977B1 KR10-2004-7013508A KR20047013508A KR100468977B1 KR 100468977 B1 KR100468977 B1 KR 100468977B1 KR 20047013508 A KR20047013508 A KR 20047013508A KR 100468977 B1 KR100468977 B1 KR 100468977B1
- Authority
- KR
- South Korea
- Prior art keywords
- polypeptides
- present
- secreted
- same
- nucleic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
Applications Claiming Priority (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11314598P | 1998-12-16 | 1998-12-16 | |
US11285198P | 1998-12-16 | 1998-12-16 | |
US60/112,851 | 1998-12-16 | ||
US60/113,145 | 1998-12-16 | ||
US11351198P | 1998-12-22 | 1998-12-22 | |
US60/113,511 | 1998-12-22 | ||
US11556599P | 1999-01-12 | 1999-01-12 | |
US11573399P | 1999-01-12 | 1999-01-12 | |
US11555899P | 1999-01-12 | 1999-01-12 | |
US60/115,733 | 1999-01-12 | ||
US60/115,565 | 1999-01-12 | ||
US60/115,558 | 1999-01-12 | ||
US11934199P | 1999-02-09 | 1999-02-09 | |
US60/119,341 | 1999-02-09 | ||
US11953799P | 1999-02-10 | 1999-02-10 | |
US60/119,537 | 1999-02-10 | ||
US11996599P | 1999-02-12 | 1999-02-12 | |
US60/119,965 | 1999-02-12 | ||
USPCT/US99/12252 | 1999-06-02 | ||
PCT/US1999/012252 WO1999063088A2 (en) | 1998-06-02 | 1999-06-02 | Membrane-bound proteins and nucleic acids encoding the same |
PCT/US1999/028634 WO2000036102A2 (en) | 1998-12-16 | 1999-12-01 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-7007461A Division KR100468978B1 (en) | 1998-12-16 | 1999-12-01 | Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040096629A KR20040096629A (en) | 2004-11-16 |
KR100468977B1 true KR100468977B1 (en) | 2005-02-02 |
Family
ID=27578476
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-7007461A KR100468978B1 (en) | 1998-12-16 | 1999-12-01 | Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
KR10-2004-7013508A KR100468977B1 (en) | 1998-12-16 | 1999-12-01 | Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-7007461A KR100468978B1 (en) | 1998-12-16 | 1999-12-01 | Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1141285A2 (en) |
JP (5) | JP2003521229A (en) |
KR (2) | KR100468978B1 (en) |
AU (7) | AU777006B2 (en) |
CA (1) | CA2348757A1 (en) |
IL (11) | IL142794A0 (en) |
MX (1) | MXPA01006057A (en) |
WO (1) | WO2000036102A2 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7419663B2 (en) | 1998-03-20 | 2008-09-02 | Genentech, Inc. | Treatment of complement-associated disorders |
US8007798B2 (en) | 1997-11-21 | 2011-08-30 | Genentech, Inc. | Treatment of complement-associated disorders |
US7192589B2 (en) | 1998-09-16 | 2007-03-20 | Genentech, Inc. | Treatment of inflammatory disorders with STIgMA immunoadhesins |
US8088386B2 (en) | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
US6914130B2 (en) * | 1998-06-17 | 2005-07-05 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
EE05497B1 (en) * | 1999-03-11 | 2011-12-15 | Rmf Dictagene S.A. | A polypeptide, a soluble CRAM-1 polypeptide, a polynucleotide, and an antibody |
AU2008201101B2 (en) * | 1999-03-11 | 2011-01-20 | Merck Serono Sa | Vascular adhesion molecules and modulation of their function |
KR100543857B1 (en) * | 1999-09-01 | 2006-01-23 | 제넨테크, 인크. | Promotion or Inhibition of Angiogenesis and Cardiovascularization |
DE19947010A1 (en) * | 1999-09-30 | 2001-04-05 | Universitaetsklinikum Freiburg | The PRV-1 gene and its use |
WO2001083719A2 (en) * | 2000-04-28 | 2001-11-08 | Millennium Pharmaceuticals, Inc. | 25692, a novel human o-methyltransferase family member and uses thereof |
GB0110273D0 (en) * | 2001-04-26 | 2001-06-20 | Inpharmatica Ltd | Novel proteins |
AU2002335054A1 (en) * | 2001-12-19 | 2003-07-09 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
US20070191402A1 (en) * | 2002-05-17 | 2007-08-16 | Kyowa Hakko Kogyo Co., Ltd. | Method of searching substrate having antidiabetic activity |
US20050283842A1 (en) * | 2002-10-02 | 2005-12-22 | Karsten Eulenberg | Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
HUE026423T2 (en) | 2005-11-04 | 2016-05-30 | Genentech Inc | Use of complement pathway inhibitors to treat ocular diseases |
US8007797B2 (en) | 2006-09-28 | 2011-08-30 | Merck Serono S.A. | Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use |
MY183804A (en) | 2006-11-02 | 2021-03-16 | Genentech Inc | Humanized anti-factor d antibodies |
AR066660A1 (en) | 2007-05-23 | 2009-09-02 | Genentech Inc | PREVENTION AND TREATMENT OF EYE CONDITIONS ASSOCIATED WITH THEIR COMPLEMENT |
CR20170001A (en) | 2008-04-28 | 2017-08-10 | Genentech Inc | ANTI FACTOR D HUMANIZED ANTIBODIES |
PE20141549A1 (en) | 2008-05-06 | 2014-10-25 | Genentech Inc | MATURE CRIG VARIANTS BY AFFINITY |
KR20160042438A (en) | 2013-08-12 | 2016-04-19 | 제넨테크, 인크. | Compositions and method for treating complement-associated conditions |
TW201623337A (en) | 2014-05-01 | 2016-07-01 | 建南德克公司 | Anti-Factor D antibody variants and uses thereof |
EP3368090A1 (en) | 2015-10-30 | 2018-09-05 | H. Hoffnabb-La Roche Ag | Anti-factor d antibody variant conjugates and uses thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001970A (en) * | 1994-11-07 | 1999-12-14 | Merck & Co., Inc | Modified human neuropeptide Y1 Receptors |
AU1532697A (en) * | 1996-01-12 | 1997-08-01 | Genetics Institute Inc. | Beta-chemokine, h1305 (mcp-2) |
JP3646191B2 (en) * | 1996-03-19 | 2005-05-11 | 大塚製薬株式会社 | Human gene |
AU746956B2 (en) * | 1997-05-06 | 2002-05-09 | Zymogenetics Inc. | Novel tumor antigens |
DE19818620A1 (en) * | 1998-04-21 | 1999-10-28 | Metagen Gesellschaft Fuer Genomforschung Mbh | New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents |
EP1090118A2 (en) * | 1998-06-26 | 2001-04-11 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
WO2000004135A2 (en) * | 1998-07-16 | 2000-01-27 | Incyte Pharmaceuticals, Inc. | Human scad-related molecules, scrm-1 and scrm-2 |
DE19849044A1 (en) * | 1998-10-23 | 2000-04-27 | Univ Ludwigs Albert | New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
WO2000029583A2 (en) * | 1998-11-19 | 2000-05-25 | Incyte Pharmaceuticals, Inc. | Immunoglobulin superfamily proteins |
DK1623989T3 (en) * | 1999-03-08 | 2007-10-15 | Genentech Inc | Compositions and Methods for Diagnosing Tumors |
-
1999
- 1999-12-01 KR KR10-2001-7007461A patent/KR100468978B1/en not_active IP Right Cessation
- 1999-12-01 IL IL14279499A patent/IL142794A0/en active IP Right Grant
- 1999-12-01 CA CA002348757A patent/CA2348757A1/en not_active Abandoned
- 1999-12-01 KR KR10-2004-7013508A patent/KR100468977B1/en not_active IP Right Cessation
- 1999-12-01 WO PCT/US1999/028634 patent/WO2000036102A2/en active Application Filing
- 1999-12-01 MX MXPA01006057A patent/MXPA01006057A/en active IP Right Grant
- 1999-12-01 EP EP99962992A patent/EP1141285A2/en not_active Withdrawn
- 1999-12-01 AU AU19320/00A patent/AU777006B2/en not_active Expired
- 1999-12-01 JP JP2000588351A patent/JP2003521229A/en not_active Withdrawn
-
2001
- 2001-04-25 IL IL142794A patent/IL142794A/en not_active IP Right Cessation
-
2003
- 2003-08-14 JP JP2003293651A patent/JP2004041218A/en not_active Withdrawn
- 2003-08-14 JP JP2003293650A patent/JP2004041217A/en not_active Withdrawn
-
2004
- 2004-12-10 AU AU2004237842A patent/AU2004237842B2/en not_active Expired
- 2004-12-14 AU AU2004237920A patent/AU2004237920B2/en not_active Expired
- 2004-12-14 AU AU2004237922A patent/AU2004237922B2/en not_active Expired
- 2004-12-14 AU AU2004237923A patent/AU2004237923B2/en not_active Expired
- 2004-12-14 AU AU2004237919A patent/AU2004237919B2/en not_active Expired
- 2004-12-14 AU AU2004237921A patent/AU2004237921B2/en not_active Expired
-
2006
- 2006-10-17 JP JP2006282251A patent/JP2007075118A/en not_active Withdrawn
-
2007
- 2007-06-13 JP JP2007156006A patent/JP2007312779A/en not_active Withdrawn
-
2008
- 2008-01-03 IL IL188580A patent/IL188580A0/en unknown
- 2008-01-03 IL IL188581A patent/IL188581A0/en unknown
- 2008-01-03 IL IL188578A patent/IL188578A0/en unknown
- 2008-01-03 IL IL188576A patent/IL188576A0/en unknown
- 2008-01-03 IL IL188579A patent/IL188579A0/en unknown
- 2008-01-03 IL IL188577A patent/IL188577A0/en unknown
-
2009
- 2009-09-13 IL IL200883A patent/IL200883A0/en unknown
- 2009-09-17 IL IL201001A patent/IL201001A0/en unknown
- 2009-09-17 IL IL201030A patent/IL201030A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL134968A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU3774300A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
MXPA01002592A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same. | |
WO2001016318A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2001040466A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000053756A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000077037A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2001068848A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2002008288A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO1999028462A3 (en) | Polypeptides and nucleic acids encoding the same | |
KR100468977B1 (en) | Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same | |
WO1999063088A8 (en) | Membrane-bound proteins and nucleic acids encoding the same | |
WO2002024888A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000032776A3 (en) | Secreted amd transmembrane polypeptides and nucleic acids encoding the same | |
PT1609863E (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
KR100515858B1 (en) | PRO617 Polypeptides | |
EP1659177A3 (en) | Secreted and transmembrane polypeptides and nucleic acids ancoding the same | |
EP1612220A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
EP1300417A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
KR100514268B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
KR100514267B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
EP1241187A3 (en) | Fibilin-like polypeptide and nucleic acids encoding the same | |
ZA200103757B (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same. | |
KR100515855B1 (en) | PRO351 Polypeptides | |
KR100515856B1 (en) | PRO618 Polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20090109 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |